サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1518571

早期毒性試験の市場レポート：技術、エンドユーザー、地域別、2024年～2032年

Early Toxicity Testing Market Report by Technique (In Vivo, In Vitro, In Silico), End User (Pharmaceuticals Industry, Food Industry, Chemicals Industry, Cosmetics Industry, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
早期毒性試験の市場レポート：技術、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の早期毒性試験の市場規模は2023年に13億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに24億米ドルに達し、2024年から2032年の間に7.2％の成長率（CAGR）を示すと予測しています。

新規化合物の早期毒性試験は、医薬品の開発や既存分子の治療可能性の拡大に用いられます。毒性試験は、前臨床段階で様々な生物学的系に対して実施され、製品の生物種、臓器、用量特異的な毒性影響を調査します。動物を用いたin vivo、アッセイを用いた実験室でのin vitro、コンピューター上でのin silicoなど、さまざまな方法で実施されます。また、物質への偶発的な暴露の研究にも活用されています。現在では、医薬品候補の後期段階での失敗が高コストに影響するため、製薬会社は治験薬について早期に毒性試験を実施するよう促しています。

早期毒性試験の市場傾向：

有害化学物質への曝露は、皮膚接触、経口摂取、吸入によって起こる。そのため、早期毒性試験は、製品の毒性の程度を判定し、ヒトの消費および環境に対する安全性を確保するために、様々な産業用途において極めて重要なプロセスとなっています。例えば、飲食品（F&B）産業では、製品に含まれる潜在的な毒性物質を特定し、その有害性を評価するために広く利用されています。さらに、疾病の有病率の上昇と新規医薬品および生物学的製剤の必要性が、臨床試験での候補医薬品の失敗を防ぐために、早期毒性試験の採用を促しています。さらに、規制当局が課す公衆衛生福祉に関する厳しい規制が、規制当局の承認に必要な医薬品の実行可能性を判断するための早期毒性試験の需要にプラスの影響を与えています。これとは別に、農薬の使用量の増加は、人間の健康にリスクをもたらす可能性があり、これが農業産業における早期毒性試験の使用を促進しています。さらに、化粧品への需要の高まりは、化粧品成分の早期毒性試験の適用を世界的に拡大しています。

本レポートで扱う主な質問

  • 世界の早期毒性試験市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の早期毒性試験市場に与えた影響は？
  • 主要な地域市場は？
  • 技術に基づく市場の内訳は？
  • エンドユーザーに基づく市場の内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な推進要因と課題は何か？
  • 世界の早期毒性試験市場の構造と主要プレーヤーは？
  • 業界における競争の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の早期毒性試験市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • In vivo
    • 市場動向
    • 市場予測
  • In vitro（体外）
    • 市場動向
    • 市場予測
  • シミュレーション
    • 市場動向
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 医薬品業界
    • 市場動向
    • 市場予測
  • 食品業界
    • 市場動向
    • 市場予測
  • 化学産業
    • 市場動向
    • 市場予測
  • 化粧品業界
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation
    • Enzo Biochem Inc.
    • Eurofins Scientific SE
    • Evotec A.G.
    • Merck KGaA
    • PerkinElmer Inc.
    • SGS S.A.
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec
図表

List of Figures

  • Figure 1: Global: Early Toxicity Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Early Toxicity Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Early Toxicity Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Early Toxicity Testing Market: Breakup by Technique (in %), 2023
  • Figure 5: Global: Early Toxicity Testing Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Early Toxicity Testing Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Early Toxicity Testing (In Vivo) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Early Toxicity Testing (In Vivo) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Early Toxicity Testing (In Vitro) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Early Toxicity Testing (In Vitro) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Early Toxicity Testing (In Silico) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Early Toxicity Testing (In Silico) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Early Toxicity Testing (Food Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Early Toxicity Testing (Food Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Early Toxicity Testing (Chemicals Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Early Toxicity Testing (Chemicals Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Early Toxicity Testing (Cosmetics Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Early Toxicity Testing (Cosmetics Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Early Toxicity Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Early Toxicity Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: North America: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: North America: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: United States: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: United States: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Canada: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Canada: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Asia-Pacific: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Asia-Pacific: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: China: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: China: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Japan: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Japan: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: India: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: India: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: South Korea: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: South Korea: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Australia: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Australia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Indonesia: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Indonesia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Europe: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Europe: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Germany: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Germany: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: France: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: France: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United Kingdom: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United Kingdom: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Italy: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Italy: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Spain: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Spain: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Russia: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Russia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Brazil: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Brazil: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Mexico: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Mexico: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Early Toxicity Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Middle East and Africa: Early Toxicity Testing Market: Breakup by Country (in %), 2023
  • Figure 71: Middle East and Africa: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Global: Early Toxicity Testing Industry: SWOT Analysis
  • Figure 73: Global: Early Toxicity Testing Industry: Value Chain Analysis
  • Figure 74: Global: Early Toxicity Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Early Toxicity Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Early Toxicity Testing Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 3: Global: Early Toxicity Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Early Toxicity Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Early Toxicity Testing Market: Competitive Structure
  • Table 6: Global: Early Toxicity Testing Market: Key Players
目次
Product Code: SR112024A5651

The global early toxicity testing market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:

Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global early toxicity testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technique and end user.

Breakup by Technique:

In Vivo

In Vitro

In Silico

Breakup by End User:

Pharmaceuticals Industry

Food Industry

Chemicals Industry

Cosmetics Industry

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Key Questions Answered in This Report:

  • How has the global early toxicity testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global early toxicity testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technique?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global early toxicity testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Early Toxicity Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 In Silico
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Pharmaceuticals Industry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Food Industry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemicals Industry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cosmetics Industry
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bio-Rad Laboratories Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bruker Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Charles River Laboratories International Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Enzo Biochem Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Eurofins Scientific SE
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evotec A.G.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Merck KGaA
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 SGS S.A.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 WuXi AppTec
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials